AI-generated summary
The authors report a case of one 5-year-old boy with autism spectrum disorder who had serial urine metal tests before and after pulsed 660 nm light therapy. Urinary aluminum rose after treatment, peaking on Day 7, and stayed above the reference range at two months. The authors state this is hypothesis-generating only and cannot establish mobilization, reduced tissue burden or clinical benefit.
- Participants
- 1
- Who or what was studied
- One 5-year-old boy with autism spectrum disorder
- Wavelengths
- 660 nm
- Limits stated in the abstract
- Single case with no control group, and the authors state that urinary aluminum alone cannot establish systemic mobilization, reduced tissue burden or clinical benefit.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Aluminum neurotoxicity has been implicated in neurodevelopmental disorders, including autism spectrum disorder (ASD). Nonchelation approaches that may influence urinary metal excretion remain largely unexplored. Photobiomodulation (PBM) at 660 nm modulates mitochondrial cytochrome c oxidase activity and cellular bioenergetics, with possible downstream effects on renal physiology. CASE: A 5-year-old boy with ASD and a historical elevated urinary aluminum result (220 µg/g creatinine at age 3) underwent serial urine toxic metals testing.
Methods
Eight spot urine specimens (November 7-19, 2025) were analyzed by ICP-MS/MS (Doctor's Data, Inc.) at 27Al, with creatinine by Jaffé reaction. Two baseline specimens preceded pulsed 660 nm PBM initiation. A follow-up specimen was collected January 21, 2026.
Intervention
Pulsed 660 nm PBM via multi-diode red laser (Program #1: 9/33/60 Hz, 15 min/session, 3 × /day) on Days 3-8. Specimens collected as consistent first morning voids.
Results
Baseline urinary aluminum was stable (10.0 and 9.8 µg/g creatinine; reference <40). After PBM, aluminum rose to 58 µg/g on Day 3 and peaked at 98 µg/g on Day 7. A severely dilute Day 8 specimen was excluded. At two-month follow-up, aluminum remained above reference (49 µg/g). Mercury exceeded reference in all specimens including baseline. Follow-up mercury rose to 8.4 µg/g creatinine with urine pH >8.0.
Conclusion
This case describes a temporal increase in urinary aluminum excretion following pulsed 660 nm PBM. Urinary aluminum alone is insufficient to establish systemic mobilization, reduced tissue burden, or clinical benefit. The observation is hypothesis-generating; controlled studies with verified dosimetry and validated outcomes are warranted.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Autism, Case report, Cytochrome c oxidase, Dosimetry, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.